Answer
Yes, nausea and vomiting are listed as common adverse reactions to sodium phenylbutyrate, meaning they occur in at least 1 in 100 but fewer than 1 in 10 patients.
Sources for this answer
- PHEBURANE 350 mg/mL oral solutionEurocept International bv · emc · SmPC §4.8 Undesirable effects · Version 1Document updated
Sources checked